The Supreme Court appears unlikely to limit access to mifepristone, commonly known as the abortion pill.
Julie Marie Blake, senior counsel of Alliance Defending Freedom, the organization representing the plaintiffs opposed to the FDA’s mifepristone policies, explains how the regulator is failing to protect women’s health.
Sarah Parshall Perry, senior legal fellow of The Heritage Foundation, argues that doctors opposed to abortion need greater protections.
